Naltrexone does not affect isoflurane minimum alveolar concentration in cats

Robert J Brosnan, Bruno H Pypendop, Chalon R. Majewski-Tiedeken, Yael Shilo-Benjamini, Jan Ilkiw

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To test whether naltrexone, an opioid receptor antagonist, affects the minimum alveolar concentration (MAC) of isoflurane in cats, a species that is relatively resistant to the general anesthetic sparing effects of most opioids. Study design: Randomized, crossover, placebo-controlled, blinded experimental design. Animals: Six healthy adult cats weighing 4.9 ± 0.7 kg. Methods: The cats were studied twice. In the first study, baseline isoflurane MAC was measured in duplicate. The drug (saline control or 0.6 mg kg-1 naltrexone) was administered IV every 40-60 minutes, and isoflurane MAC was re-measured. In the second study, cats received the second drug treatment using identical methods 2 weeks later. Results: Isoflurane MAC was 2.03 ± 0.12% and was unchanged from baseline following saline or naltrexone administration. Conclusion and clinical relevance: Minimum alveolar concentration was unaffected by naltrexone. Because MAC in cats is unaffected by at least some mu-opioid agonists and antagonists, spinal neurons that are directly modulated by mu-opioid receptors in this species cannot be the neuroanatomic sites responsible for immobility from inhaled anesthetics.

Original languageEnglish (US)
Pages (from-to)225-228
Number of pages4
JournalVeterinary Anaesthesia and Analgesia
Volume40
Issue number2
DOIs
StatePublished - Mar 2013

Fingerprint

Naltrexone
Isoflurane
isoflurane
narcotics
Cats
cats
Narcotic Antagonists
Anesthetics
antagonists
experimental design
general anesthetics
General Anesthetics
receptors
mu Opioid Receptor
Drug and Narcotic Control
anesthetics
Cross-Over Studies
Opioid Analgesics
agonists
drug therapy

Keywords

  • Cats
  • Isoflurane
  • Minimum alveolar concentration
  • Naltrexone

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Naltrexone does not affect isoflurane minimum alveolar concentration in cats. / Brosnan, Robert J; Pypendop, Bruno H; Majewski-Tiedeken, Chalon R.; Shilo-Benjamini, Yael; Ilkiw, Jan.

In: Veterinary Anaesthesia and Analgesia, Vol. 40, No. 2, 03.2013, p. 225-228.

Research output: Contribution to journalArticle

@article{3a55b4deb044413ebfac32eb2a93fdf5,
title = "Naltrexone does not affect isoflurane minimum alveolar concentration in cats",
abstract = "Objective: To test whether naltrexone, an opioid receptor antagonist, affects the minimum alveolar concentration (MAC) of isoflurane in cats, a species that is relatively resistant to the general anesthetic sparing effects of most opioids. Study design: Randomized, crossover, placebo-controlled, blinded experimental design. Animals: Six healthy adult cats weighing 4.9 ± 0.7 kg. Methods: The cats were studied twice. In the first study, baseline isoflurane MAC was measured in duplicate. The drug (saline control or 0.6 mg kg-1 naltrexone) was administered IV every 40-60 minutes, and isoflurane MAC was re-measured. In the second study, cats received the second drug treatment using identical methods 2 weeks later. Results: Isoflurane MAC was 2.03 ± 0.12{\%} and was unchanged from baseline following saline or naltrexone administration. Conclusion and clinical relevance: Minimum alveolar concentration was unaffected by naltrexone. Because MAC in cats is unaffected by at least some mu-opioid agonists and antagonists, spinal neurons that are directly modulated by mu-opioid receptors in this species cannot be the neuroanatomic sites responsible for immobility from inhaled anesthetics.",
keywords = "Cats, Isoflurane, Minimum alveolar concentration, Naltrexone",
author = "Brosnan, {Robert J} and Pypendop, {Bruno H} and Majewski-Tiedeken, {Chalon R.} and Yael Shilo-Benjamini and Jan Ilkiw",
year = "2013",
month = "3",
doi = "10.1111/vaa.12004",
language = "English (US)",
volume = "40",
pages = "225--228",
journal = "Veterinary Anaesthesia and Analgesia",
issn = "1467-2987",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Naltrexone does not affect isoflurane minimum alveolar concentration in cats

AU - Brosnan, Robert J

AU - Pypendop, Bruno H

AU - Majewski-Tiedeken, Chalon R.

AU - Shilo-Benjamini, Yael

AU - Ilkiw, Jan

PY - 2013/3

Y1 - 2013/3

N2 - Objective: To test whether naltrexone, an opioid receptor antagonist, affects the minimum alveolar concentration (MAC) of isoflurane in cats, a species that is relatively resistant to the general anesthetic sparing effects of most opioids. Study design: Randomized, crossover, placebo-controlled, blinded experimental design. Animals: Six healthy adult cats weighing 4.9 ± 0.7 kg. Methods: The cats were studied twice. In the first study, baseline isoflurane MAC was measured in duplicate. The drug (saline control or 0.6 mg kg-1 naltrexone) was administered IV every 40-60 minutes, and isoflurane MAC was re-measured. In the second study, cats received the second drug treatment using identical methods 2 weeks later. Results: Isoflurane MAC was 2.03 ± 0.12% and was unchanged from baseline following saline or naltrexone administration. Conclusion and clinical relevance: Minimum alveolar concentration was unaffected by naltrexone. Because MAC in cats is unaffected by at least some mu-opioid agonists and antagonists, spinal neurons that are directly modulated by mu-opioid receptors in this species cannot be the neuroanatomic sites responsible for immobility from inhaled anesthetics.

AB - Objective: To test whether naltrexone, an opioid receptor antagonist, affects the minimum alveolar concentration (MAC) of isoflurane in cats, a species that is relatively resistant to the general anesthetic sparing effects of most opioids. Study design: Randomized, crossover, placebo-controlled, blinded experimental design. Animals: Six healthy adult cats weighing 4.9 ± 0.7 kg. Methods: The cats were studied twice. In the first study, baseline isoflurane MAC was measured in duplicate. The drug (saline control or 0.6 mg kg-1 naltrexone) was administered IV every 40-60 minutes, and isoflurane MAC was re-measured. In the second study, cats received the second drug treatment using identical methods 2 weeks later. Results: Isoflurane MAC was 2.03 ± 0.12% and was unchanged from baseline following saline or naltrexone administration. Conclusion and clinical relevance: Minimum alveolar concentration was unaffected by naltrexone. Because MAC in cats is unaffected by at least some mu-opioid agonists and antagonists, spinal neurons that are directly modulated by mu-opioid receptors in this species cannot be the neuroanatomic sites responsible for immobility from inhaled anesthetics.

KW - Cats

KW - Isoflurane

KW - Minimum alveolar concentration

KW - Naltrexone

UR - http://www.scopus.com/inward/record.url?scp=84873726137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873726137&partnerID=8YFLogxK

U2 - 10.1111/vaa.12004

DO - 10.1111/vaa.12004

M3 - Article

C2 - 23279646

AN - SCOPUS:84873726137

VL - 40

SP - 225

EP - 228

JO - Veterinary Anaesthesia and Analgesia

JF - Veterinary Anaesthesia and Analgesia

SN - 1467-2987

IS - 2

ER -